World Pharma Today

CordenPharma, a global contract development and manufacturing organization specializing in complex drug modalities, has officially entered into an agreement to acquire AmbioPharm. The AmbioPharm Deal strengthens the company’s manufacturing presence in the United States while adding newly integrated production capabilities in Shanghai, China. The move allows CordenPharma to co...

Ahead of BIO San Diego next month, Shilpa Biologicals has called on emerging biotech companies to rethink how they approach CDMO Selection as investment conditions begin to improve across the biopharma sector. Madhav Bhutada, Director of Shilpa Biologicals, said many innovators developing increasingly sophisticated therapies, including bispecific and trispecific antibodies, c...

Clinical trials are the foundation of modern medicine. Every treatment, therapy, and medical breakthrough relies on accurate research to ensure safety and effectiveness. However, maintaining accuracy across complex studies has always been a challenge. With large patient populations, multiple trial sites, and increasing volumes of data, research teams must work harder than eve...

Medicines optimisation in primary care became a formal discipline in 2013, when the Royal Pharmaceutical Society set out a four-principle framework that has guided the work ever since. The language was new at the time, but the underlying ideas were not. The framework redirected clinical attention from the medicine to the patient taking it and […]

MSD and Adcendo have established a collaboration and supply agreement to evaluate the combination of ADCE-T02 and pembrolizumab. The companies are preparing for a Phase Ib solid tumour clinical trial targeting patients with advanced solid tumours. Adcendo will act as the sponsor for the solid tumour clinical trial, with MSD providing pembrolizumab. ADCE-T02 is an […]